Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a differentiated non-immunosuppressive approach to inflammatory heart disease. The company’s 2025–2026 catalysts – MAVERIC Phase III enrollment progress, full ARCHER data, and CRD-38 clinical initiation – are key value drivers in…
On Thursday (September 11), Canadian Prime Minister Mark Carney revealed the first tranche of projects selected by the newly…
Here’s a quick recap of the crypto landscape for Wednesday (September 10) as of 9:00 p.m. UTC. Get the…
Vancouver, British Columbia September 11, 2025 Rio Silver Inc. (‘Rio Silver’ or the ‘Company’) (TSX.V: RYO,OTC:RYOOD) (OTC: RYOOF) announces…
Altech Batteries (ATC:AU) has announced ALTECH – CERENERGY Battery Prototype Reaches Key Milestones Download the PDF here. This post…
Newmont (TSX:NGT,NYSE:NEM,ASX:NEM) is preparing to withdraw from the Toronto Stock Exchange later this month, the latest in a string…
Canadian Prime Minister Mark Carney has announced the country’s first five nation-building projects. In March and April, the Build…
Perth, Australia (ABN Newswire) – Altech Batteries Limited (ASX:ATC,OTC:ALTHF) (FRA:A3Y) (OTCMKTS:ALTHF) is pleased to announce the latest performance results…
Platinum is heading for a third consecutive annual deficit in 2025, with the World Platinum Investment Council (WPIC) projecting…